Benzokain Sprey — Competitive Intelligence Brief

Benzokain Sprey (Benzokain Sprey) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Pain management / Anesthesia.

phase 3 Local anesthetic Voltage-gated sodium channels Pain management / Anesthesia Small molecule

Target snapshot

Benzokain Sprey (Benzokain Sprey) — TC Erciyes University. Benzocaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Benzokain Sprey TARGET	Benzokain Sprey	TC Erciyes University	phase 3	Local anesthetic	Voltage-gated sodium channels
Nebulized lidocaine and dexmedetomidine	Nebulized lidocaine and dexmedetomidine	Ain Shams University	marketed	Local anesthetic and sedative-analgesic combination	Voltage-gated sodium channels (lidocaine); alpha-2 adrenergic receptors (dexmedetomidine)
Lidocaine + Prilocaine	Lidocaine + Prilocaine	Galeno Desenvolvimento de Pesquisas Clínicas	marketed	Local anesthetic	Voltage-gated sodium channels
Levobupivacaine continuous infusion	Levobupivacaine continuous infusion	Fondazione IRCCS Policlinico San Matteo di Pavia	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Ropivacaine Monohydrochloride	Ropivacaine Monohydrochloride	Clinique Saint-Jean, Bruxelles	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels
lithium plus carbamazepine	lithium plus carbamazepine	University of Sao Paulo	marketed	Mood stabilizer combination	Lithium: inositol monophosphatase and GSK-3β; Carbamazepine: voltage-gated sodium channels
Hyperbaric bupivacaine+Morphine	Hyperbaric bupivacaine+Morphine	Fundación Pública Andaluza Progreso y Salud	marketed	Local anesthetic + opioid combination	Voltage-gated sodium channels (bupivacaine); mu opioid receptors (morphine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class